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Abstract
To date, two different transporters that are capable of transporting K-(methylamino)isobutyric acid, the specific substrate
for amino acid transport system A, have been cloned. These two transporters are known as ATA1 and ATA2. We have
cloned a third transporter that is able to transport the system A-specific substrate. This new transporter, cloned from rat
skeletal muscle and designated rATA3, consists of 547 amino acids and has a high degree of homology to rat ATA1 (47%
identity) and rat ATA2 (57% identity). rATA3 mRNA is present only in the liver and skeletal muscle. When expressed in
Xenopus laevis oocytes, rATA3 mediates the transport of K-[14C](methylamino)isobutyric acid and [3H]alanine. With the
two-microelectrode voltage clamp technique, we have shown that exposure of rATA3-expressing oocytes to neutral, short-
chain aliphatic amino acids induces inward currents. The amino acid-induced current is Na-dependent and pH-dependent.
Analysis of the currents with alanine as the substrate has shown that the K0:5 for alanine (i.e., concentration of the amino acid
yielding half-maximal current) is 4.2 þ 0.1 mM and that the Na :alanine stoichiometry is 1:1. ß 2000 Elsevier Science B.V.
All rights reserved.
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Recently, two subtypes of amino acid transport
system A, namely ATA1 (also known as GlnT) and
ATA2 (also known as SAT2), have been cloned from
rat and human tissues [1^6]. These transporters me-
diate the uptake of short-chain neutral amino acids
in a Na-dependent manner. The ability to transport
K-(methylamino)isobutyric acid (MeAIB), a speci¢c
substrate for amino acid transport system A, is a
distinguishing feature of ATA1 and ATA2. Prior to
the successful cloning of these transporters, function-
al studies provided little evidence for the existence of
multiple subtypes of amino acid transport system A.
System A was de¢ned traditionally as a Na-depen-
dent amino acid transport system speci¢c for short-
chain, neutral, aliphatic amino acids. In addition, the
de¢nition included the following: ability to transport
MeAIB, pH sensitivity, ubiquitous expression in
mammalian tissues, and sensitivity to hormonal reg-
ulation [7^9]. Surprisingly, when Varoqui et al. [1]
cloned ATA1 as the ¢rst amino acid transporter ca-
pable of recognizing MeAIB as a substrate, this
transporter was found to meet some, but not all, of
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the criteria used to de¢ne system A. In rat, ATA1 is
expressed primarily in the brain. In human, the ex-
pression of ATA1 is predominant in the placenta,
heart and brain [2]. Since the classical, hormone-sen-
sitive system A is known to be expressed ubiqui-
tously, ATA1 does not represent this classical system
A. Subsequently, ATA2 was cloned from rat and
human tissues [3^6]. ATA2 is also able to mediate
the transport of the system A-speci¢c substrate
MeAIB. But, unlike ATA1, ATA2 is expressed ubiq-
uitously in rat and human tissues. It is therefore very
likely that ATA2 represents the classical system A.
In this report, we describe the cloning of a third
transporter capable of mediating the uptake of
MeAIB. This transporter, designated ATA3, was
cloned from rat skeletal muscle. ATA3 meets most
of the functional criteria attributable to system A,
but has a unique tissue distribution pattern. In rat,
ATA3 is expressed abundantly in the liver and, to a
much smaller extent, in the skeletal muscle.
The SuperScript plasmid system (Life Technolo-
gies, Rockville, MD, USA) was used to establish a
unidirectional cDNA library with poly(A)mRNA
isolated from rat skeletal muscle. Poly(A)mRNA
was prepared by subjecting total RNA twice to oli-
go(dT)-cellulose a⁄nity chromatography prior to use
in a library construction. The cDNA products with
sizes greater than 1 kb were separated by size frac-
tionation and used for ligation at the SalI-NotI site
in the pSPORT1 vector.
A cDNA fragment of the recently cloned rat ami-
no acid transport system N2 (unpublished), a Na-
and H-coupled glutamine transporter similar to sys-
tem N1 [10], was used as the probe in the screening
of the rat skeletal muscle cDNA library. The screen-
ing was done under low stringency conditions as de-
scribed previously [11^13]. Positive clones were iden-
ti¢ed and colonies puri¢ed by secondary screening.
The cDNAs were sequenced using an automated Per-
kin-Elmer Applied Biosystems 377 Prism DNA se-
quencer. The sequence was analyzed using the
GCG sequence analysis software package GCG ver-
sion 10 (Genetics Computer Group, Madison, WI,
USA).
A commercially available rat multiple tissue blot
(Origene, Rockville, MD, USA) was used for North-
ern blot analysis to determine the tissue expression
pattern of ATA3. The blot was hybridized sequen-
tially under high stringency conditions with the
cloned rat ATA3 cDNA and human glyceralde-
hyde-3-phosphate dehydrogenase cDNA as the
probes.
Xenopus laevis oocytes were used for heterologous
expression of the cloned rat ATA3 for functional
analysis. cRNA from the cloned cDNA was synthe-
sized using the mMESSAGE mMACHINE kit (Am-
bion, Austin, TX, USA). The cDNA was linearized
using NotI, and the cDNA insert was transcribed in
vitro using T7 RNA polymerase in the presence of
an RNA cap analogue. The resultant cRNA was
puri¢ed by multiple extraction with phenol/chloro-
form and precipitated with isopropanol. Mature oo-
cytes were isolated by treatment with collagenase A
(1.6 mg/ml) and manually defolliculated, and main-
tained at 18‡C in modi¢ed Barth’s medium supple-
mented with 10 mg/l gentamicin [14]. Oocytes ware
injected with 50 ng of cRNA. Oocytes injected with
water served as control. The oocytes were used for
uptake or electrophysiological studies 5^6 days after
cRNA injection. Electrophysiological studies were
done by the conventional two-microelectrode voltage
clamp method [15^17]. Oocytes were perfused with a
bu¡er (100 mM NaCl, 2 mM KCl, 1 mM MgCl2,
1 mM CaCl2, pH adjusted by mixing 3 mM HEPES,
3 mM MES, and 3 mM Tris) followed by the same
bu¡er containing di¡erent amino acid substrates.
The membrane potential was held steady at 350
mV. The uptake of [3H]alanine and [14C]MeAIB in
control oocytes and rATA3-expressing oocytes was
measured as described previously [18].
The newly cloned rat ATA3 cDNA is 1946 bp long
(GenBank accession No. AF295535) and encodes a
protein containing 547 amino acids (Fig. 1). At the
level of the amino acid sequence, this clone bears
signi¢cant homology to rat ATA1 (47% identity;
63% similarity) and rat ATA2 (57% identity; 68%
similarity), two previously known subtypes of amino
acid transport system A. Rat ATA3 is longer than
rat ATA1 and rat ATA2 because of the additional
amino acid sequence located in the middle of the
protein. Hydropathy analysis indicates that rat
ATA3 has ten or 11 putative transmembrane do-
mains.
We have also isolated a second ATA3 clone from
the rat skeletal muscle cDNA library. This clone is
3934 bp long, much longer than the ¢rst clone. But
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Fig. 1. Primary structure of rat ATA3. The amino acid sequence of rat ATA3 (rATA3) is compared with that of rat ATA1 (rATA1)
and rat ATA2 (rATA2). The regions of sequence identity (dark shade) and similarity (light shade) among the three proteins are
boxed.
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sequencing of the second clone has revealed that it
contains an open reading frame exactly identical to
that of the ¢rst clone. The di¡erence between the two
clones lies in the 3P-untranslated region. These two
clones apparently arise from alternative splicing.
The functional characteristics of rat ATA3 were
studied by expressing the ¢rst clone in X. laevis
oocytes heterologously. The transport function was
evaluated by the uptake of radiolabeled amino acid
substrates as well as by electrophysiological methods.
Fig. 2 describes the uptake of [3H]alanine and
[14C]MeAIB in water-injected oocytes and in oocytes
expressing rat ATA3. The uptake of these two amino
acids was severalfold higher in ATA3-expressing oo-
cytes than in water-injected oocytes (alanine, 13-fold;
MeAIB, 2.2-fold). Since MeAIB is considered a spe-
ci¢c substrate for system A, the new transporter
clone must represent a subtype of amino acid trans-
port system A. Therefore, we have named this trans-
porter ATA3 (amino acid transporter A3).
We then studied the transport function of rat
ATA3 in oocytes by electrophysiological means. Per-
fusion of ATA3-expressing oocytes with 5 mM ala-
nine induced marked inward currents in the presence
of NaCl. The currents were negligible under identical
conditions in water-injected oocytes, showing that
alanine-induced currents were associated with rat
ATA3. The ATA3-speci¢c alanine-induced currents
were Na-dependent because the magnitude of the
currents was reduced markedly when the studies
were conducted in the presence of N-methyl-D-gluc-
amine chloride in place of NaCl. Cl3 had no role in
the transport function as is evident from the lack of
any signi¢cant change in the alanine-induced cur-
rents when studied in the presence of sodium gluco-
nate instead of NaCl. The ATA3-speci¢c alanine-in-
duced currents were, however, pH-dependent, the
magnitude of the currents increasing markedly as
the pH of the perfusion bu¡er increased from 5.5
to 8.5 (data not shown). These characteristics of rat
ATA3 are similar to those of ATA1 and ATA2.
The substrate speci¢city of rat ATA3 was then
studied by assessing the ability of various amino
acids (5 mM) to induce currents in ATA3-expressing
oocytes in the presence of NaCl. The relative magni-
tudes of the currents induced by several amino acids
are given in Fig. 3 as percentage of alanine-induced
currents (100%). The zwitterionic amino acids gly-
cine, serine, cysteine, asparagine and threonine were
excellent substrates for rat ATA3. The magnitude of
the currents induced by these amino acids was
s 50% of alanine-induced currents. Proline, methio-
nine, glutamine and histidine induced currents that
were 15^30% of alanine control. MeAIB and lysine
showed small but signi¢cant currents. The aromatic
amino acids (phenylalanine, tryptophan, and tyro-
sine) and the anionic amino acids (aspartate and glu-
tamate) were almost totally ine¡ective in inducing
currents.
We then studied the characteristics of ATA3 trans-
port function using alanine as the substrate. Alanine-
Fig. 2. Uptake of alanine (A) and MeAIB (B) by rATA3-ex-
pressing X. laevis oocytes. Uptake of [3H]alanine (200 WM) and
[14C]MeAIB (50 WM) was measured in water-injected oocytes
and in rATA3 cRNA-injected oocytes for 1 h. The uptake me-
dium (pH 8.0) contained NaCl.
Fig. 3. Substrate speci¢city of rATA3. rATA3 was expressed in
X. laevis oocytes and currents induced by various amino acids
(5 mM) were measured at pH 8.0 using the two-microelectrode
voltage clamp technique. Values are mean þ S.E. from three oo-
cytes and given as percentage of alanine-induced current. The
value for alanine-induced current in three oocytes was 93 þ 19
nA (100%).
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induced currents were saturable with alanine concen-
tration at all membrane potentials studied (310 to
3150 mV) (Fig. 4A). These data were analyzed by
Michaelis-Menten kinetics and K0:5 values for ala-
nine (i.e., concentration of alanine needed for the
induction of half-maximal current) were calculated.
The K0:5 was about 4.2 þ 0.1 mM at 350 mV. This
value was in£uenced markedly by the membrane po-
tential (Fig. 4B). Hyperpolarization of the membrane
decreased K0:5 whereas depolarization increased K0:5.
Alanine-induced currents were also related hyper-
bolically to Na concentration at all membrane po-
tentials studied (Fig. 4C). These data were analyzed
by Hill kinetics and the Hill coe⁄cient for the acti-
vation of ATA3 transport function by Na was in
the range of 0.9^1.2 depending on the membrane
potential. At 350 mV, the Hill plot was linear
with a Hill coe⁄cient of 0.96 þ 0.12 (Fig. 4D). These
data show that the substrate a⁄nity of ATA3 is
in£uenced by membrane potential and that the
Na :alanine stoichiometry is 1:1.
Northern blot analysis indicated that ATA3
mRNA is expressed most predominantly in the liver
(Fig. 5). Skeletal muscle also expressed detectable
Fig. 4. Electrophysiological characteristics of rat ATA3. (A) Alanine-induced currents were measured in rat ATA3-expressing oocytes
at pH 8.0 in the presence of NaCl. Concentration of alanine was varied in the range of 0.25^20 mM. (B) In£uence of membrane po-
tential on K0:5 for alanine (i.e., alanine concentration needed for induction of half-maximal current). (C) Alanine-induced currents
were measured in rat ATA3-expressing oocytes at pH 8.0. Alanine concentration was constant at 5 mM whereas Na concentration
was varied in the range of 5^60 mM. Osmolality and Cl3 concentration were maintained constant by appropriately altering the con-
centration of NaCl and N-methyl-D-glucamine chloride. (D) Hill plot for Na activation of alanine-induced currents at 350 mV.
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levels of the transcripts. The expression in all other
tissues such as brain, thymus, lung, heart, stomach,
small intestine, kidney, spleen, testis, and skin was
below detectable levels. Two di¡erent transcripts
were detected with sizes of 2.0 and 4.0 kb that cor-
respond to the sizes of the two clones described in
the present study.
In summary, we have cloned rat ATA3, a new
subtype of amino acid transport system A, from rat
skeletal muscle. This new transporter is expressed at
detectable levels only in the liver and skeletal muscle.
The levels of mRNA in the liver are, however, sever-
alfold higher than in the skeletal muscle. Function-
ally, this transporter is similar to ATA1 and ATA2
except for the comparatively lower substrate a⁄nity
of ATA3. The tissue expression pattern of ATA3 is
unique because ATA1 is expressed primarily in the
brain, placenta and heart while ATA2 is expressed
ubiquitously. This is the ¢rst report of the molecular
characterization of an amino acid transport system A
that is expressed abundantly only in the liver. It is
therefore obvious that liver expresses at least two
di¡erent subtypes of system A (ATA2 and ATA3).
Functional studies have shown that the amino acid
transport system A in the liver is subject to hormonal
regulation. The transport system is known to be in-
£uenced by glucagon, insulin, starvation, and preg-
nancy [19^21]. Since ATA2 as well as ATA3 are
likely to contribute to the amino acid system A ac-
tivity in the liver, a physiologically important ques-
tion arises as to the identity of the system A subtype
that is regulated by hormones. Studies are underway
in our laboratory to determine whether ATA2 and
ATA3 are regulated di¡erentially by hormones.
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